Lv4
640 积分 2024-06-11 加入
Stress Factors in mAb Drug Substance Production Processes: Critical Assessment of Impact on Product Quality and Control Strategy
19天前
已完结
A tetraspecific engager armed with a non-alpha IL-2 variant harnesses natural killer cells against B cell non-Hodgkin lymphoma
1个月前
已完结
A brief introduction of IgG-like bispecific antibody purification: Methods for removing product-related impurities
1个月前
已完结
Non-viral delivery of RNA for therapeutic T cell engineering
3个月前
已完结
CAR T cells vs bispecific antibody as third- or later-line large B-cell lymphoma therapy: a meta-analysis
7个月前
已完结
Comparison of CAR T-cell vs. bispecific antibody as third- or later-line large B-cell lymphoma therapy: A Meta-analysis
7个月前
已关闭
Engineering Macrophages for Cancer Immunotherapy and Drug Delivery
7个月前
已完结
CD16A-Specific Tetravalent Bispecific Immune Cell Engagers Potently Induce Antibody-Dependent Cellular Phagocytosis (ADCP) on Macrophages
7个月前
已关闭
Exploring the NK cell platform for cancer immunotherapy
7个月前
已完结
Advancements and challenges in developing in vivo CAR T cell therapies for cancer treatment
8个月前
已完结
皖公网安备34019202002308
